Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Clinical trial NCT01037790 · COMPLETED

Trial details

NCT number: NCT01037790
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Solid Tumor Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Adult Central Nervous System Germ Cell Tumor Adult Teratoma Benign Teratoma Estrogen Receptor-negative Breast Cancer Estrogen Receptor-positive Breast Cancer Familial Testicular Germ Cell Tumor HER2-negative Breast Cancer HER2-positive Breast Cancer Male Breast Cancer

Start date: 2009-10-01
Primary completion: 2019-10-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.